First-pass extracted concept

glia-mediated glutamate dysregulation in mood disorders

Candidate: concept label1 source documents3 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

This concept describes the review's proposed convergence of inflammation and glutamate alterations at the level of glia in mood disorders.

Source 1DOI PubMed

What problem it solves

It helps explain how immune activation could translate into synaptic and circuit dysfunction through glial control of glutamate.

Source 1DOI PubMed

What it does not solve

It does not itself specify a discrete intervention, construct, or assay in the provided abstract.

Source 1DOI PubMed

Alternatives

The abstract contrasts this integrative glial framework with considering inflammation or glutamate alterations as separate pathways.

Source 1DOI PubMed

Evidence Snippets

The primary goal of this review is to illustrate how these two pathways may converge at the level of the glia to contribute to neuropsychiatric disease.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2016NeuropsychopharmacologyDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1mechanistic modelsupports2016Source 1DOI PubMed

Increased glutamate is proposed to promote aberrant extrasynaptic signaling through ionotropic and metabotropic glutamate receptors, resulting in synaptic dysfunction and loss.

Claim 2mechanistic modelsupports2016Source 1DOI PubMed

The review proposes that immune activation causes failed glial glutamate clearance together with exaggerated glial glutamate release, increasing glutamate levels.

Claim 3review summarysupports2016Source 1DOI PubMed

Inflammation and altered glutamate neurotransmission are presented as two novel pathways contributing to mood-disorder pathophysiology.